SIMLUKAFUSP ALFA for Renal cell carcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where SIMLUKAFUSP ALFA was used for Renal cell carcinoma.
Most Reported Side Effects for SIMLUKAFUSP ALFA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug-induced liver injury | 5 | 9.3% | 2 | 3 |
Other Indications for SIMLUKAFUSP ALFA
Neoplasm (12)
Metastatic neoplasm (11)
Non-small cell lung cancer (7)
Oesophageal squamous cell carcinoma (5)
Other Drugs Used for Renal cell carcinoma
CABOZANTINIB S-MALATE (9,156)
NIVOLUMAB (6,514)
LENVATINIB (3,849)
PEMBROLIZUMAB (3,027)
SUNITINIB MALATE (2,926)
PAZOPANIB (2,799)
IPILIMUMAB (2,585)
AXITINIB (2,447)
EVEROLIMUS (1,573)
TIVOZANIB (1,258)